- Dapagliflozin Intermediate
- 4-(5-bromo-2-chlorobenzyl) phenyl ethyl ether
- (2S,3R,4R,5S,6R)-2-[4-choloro-3-(7-ethoxy benzyl) phenyl]-6-(hydro methyl)-2-ethoxy tetrahydro-2H-pyran-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-(Acetoxy methyl)-6-[4-chloro-3-(4- ethoxy benzyl) phenyl] tetrahydro-2H-pyran-3,4,5-triyl triacetate
4-(5-bromo-2-chlorobenzyl) phenyl ethyl ether
| API Name | Dapagliflozin Intermediate |
| Intermediate Name | 4-(5-bromo-2-chlorobenzyl) phenyl ethyl ether |
| CAS No. | 461432-23-5 |
| Stage | Commercial |
Disclaimer
I - Products protected by patents are developed solely for the R&D purpose intended to support regulatory submissions.
II - It is within the buyer's responsibility and liability to check the patent situation of the products in the import market(s).
I - Products protected by patents are developed solely for the R&D purpose intended to support regulatory submissions.
II - It is within the buyer's responsibility and liability to check the patent situation of the products in the import market(s).
